Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?

References

• Teo MC. (2014). Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer. Curr Opin Obstet Gynecol 26:3–8.
   PubMed Web of Science ®Google Scholar
• Teo MC, Ching Tan GH, Lim C, et al. (2015). Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center. Asian J Surg/Asian Surg Assoc 38:65–73.
   PubMed Web of Science ®Google Scholar
• Teo MC, Tan GH, Tham CK, et al. (2013). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Ann Surg Oncol 20:2968–74.
   PubMed Web of Science ®Google Scholar
• Sadeghi B, Arvieux C, Glehen O, et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–63.
   PubMed Web of Science ®Google Scholar
• Mirnezami R, Mehta AM, Chandrakumaran K, et al. (2014). Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer 111:1500–8.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, Bruin S, Boot H, et al. (2008). 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. (2003). Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–43.
   PubMed Web of Science ®Google Scholar
• Yan TD, Deraco M, Baratti D, et al. (2009). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–42.
   PubMed Web of Science ®Google Scholar
• Klumpp B, Aschoff P, Schwenzer N, et al. (2013). Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results. Cancer Imaging 13:540–7.
   PubMed Web of Science ®Google Scholar
• Baumgartner JM, Tobin L, Heavey SF, et al. (2015). Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 22:1716–21.
   PubMed Web of Science ®Google Scholar
• Tan G, Chia C, Kumar M, et al. (2017). 201 Consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre. Int J Hyperthermia 33:288–94.
   PubMed Web of Science ®Google Scholar
• Lin EK, Hsieh MC, Chen CH, et al. (2016). Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis. Medicine 95:e5522.
   PubMed Web of Science ®Google Scholar
• van Oudheusden TR, Braam HJ, Luyer MD, et al. (2015). Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol 22:1236–42.
   PubMed Web of Science ®Google Scholar
• Iversen LH, Rasmussen PC, Laurberg S. (2013). Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92.
   PubMed Web of Science ®Google Scholar
• Yong ZZ, Tan GH, Wong JF, et al. (2016). Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia 32:889–94.
   PubMed Web of Science ®Google Scholar
• Jayakrishnan TT, Zacharias AJ, Sharma A, et al. (2014). Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 12:270.
   PubMed Web of Science ®Google Scholar
• Wiering B, Krabbe PF, Jager GJ, et al. (2005). The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104:2658–70.
   PubMed Web of Science ®Google Scholar
• de Bree E, Koops W, Kroger R, et al. (2006). Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32:65–71.
   PubMed Web of Science ®Google Scholar
• Tan GH, Kwek JW, Hosseini R, et al. (2016). Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies. J Med Imaging Radiat Oncol 60:337–43.
   PubMed Web of Science ®Google Scholar
• Flicek K, Ashfaq A, Johnson CD, et al. (2016). Correlation of radiologic with surgical peritoneal cancer index scores in patients with pseudomyxoma peritonei and peritoneal carcinomatosis: how well can we predict resectability? J Gastrointestinal Surg 20:307–12.
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez V, Cascales-Campos PA, Gil J, et al. (2016). Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. Eur J Radiol 85:1824–8.
   PubMed Web of Science ®Google Scholar
• Pasqual EM, Bertozzi S, Bacchetti S, et al. (2014). Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery. Anticancer Res 34:2363–8.
   PubMed Web of Science ®Google Scholar
• De Vos N, Goethals I, Ceelen W. (2014). Clinical value of (18)F-FDG- PET-CT in the preoperative staging of peritoneal carcinomatosis from colorectal origin. Acta Chirurgica Belgica 114:370–5.
   PubMed Web of Science ®Google Scholar
• Alessi A, Martinelli F, Padovano B, et al. (2016). FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results. Tumori 102:103–7.
   PubMed Web of Science ®Google Scholar
• Lake ES, Wadhwani S, Subar D, et al. (2014). The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis. Ann R Coll Surgeons England 96:211–5.
   PubMed Web of Science ®Google Scholar
• Yip VS, Poston GJ, Fenwick SW, et al. (2014). FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases. Eur J Surg Oncol 40:995–9.
   PubMed Web of Science ®Google Scholar
• Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF. (2011). Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. Clin Radiol 66:1167–74.
   PubMed Web of Science ®Google Scholar
• Whiteford MH, Whiteford HM, Yee LF, et al. (2000). Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759–67. discussion 67–70.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kawai Y, Kanai M, et al. (2002). Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 184:433–6.
   PubMed Web of Science ®Google Scholar
• Pfannenberg C, Konigsrainer I, Aschoff P, et al. (2009). 18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 16:1295–303.
   PubMed Web of Science ®Google Scholar
• Turlakow A, Yeung HW, Salmon AS, et al. (2003). Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nuclear Med 44:1407–12.
   PubMed Web of Science ®Google Scholar
• Pelosi E, Deandreis D. (2007). The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Eur J Surg Oncol 33:1–6.
   PubMed Web of Science ®Google Scholar
• Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM. (2016). Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol 23:1461–7.
   PubMed Web of Science ®Google Scholar